NCT04787419 is a Phase 2, PHASE3 clinical trial of probiotics in Cholestatic Liver Disease, sponsored by Indonesia University.

Who is sponsoring NCT04787419?

NCT04787419 is sponsored by Indonesia University.

What drugs are being tested in NCT04787419?

Interventions in NCT04787419: placebo, probiotics.

What condition does NCT04787419 study?

NCT04787419 studies Cholestatic Liver Disease.

Is NCT04787419 still recruiting?

NCT04787419 is currently status unknown. Last updated 3 March 2023.

Last reviewed 2023-03-03 · How we verify

NCT04787419

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Probiotics in Pediatric Chronic Cholestasis

Status unknown Phase 2, PHASE3 Last updated 3 March 2023

What this trial tests

Phase 2, PHASE3 trial testing placebo in Cholestatic Liver Disease in 60 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
1 December 2023

1 December 2023

Quick facts

Lead sponsor	Indonesia University
Phase	Phase 2, PHASE3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	60
Start date	1 September 2020
Primary completion	1 December 2023
Estimated completion	1 December 2023
Sites	1 location across Indonesia

Drugs / interventions tested

placebo
probiotics — full drug profile →

Conditions studied

Cholestatic Liver Disease — all drugs for Cholestatic Liver Disease →

Sponsor

Indonesia University

Who can join

Adults 29 Days to 215 Months, any sex, with Cholestatic Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

double blinded RCT (probiotics vs placebo) given to pediatric patients with chronic cholestasis for 4 weeks duration. baseline characteristics (antropometry, gastrointestinal symptoms, laboratory examinations) would be compared pre vs post treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of probiotics

Trials testing the same drug.

NCT07333313 — Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic · NA · recruiting
NCT07182942 — The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease · Phase 4 · recruiting
NCT06554314 — Effect of Probiotics on Regulating Gut Health and Blood Lipid in Adults · NA · recruiting
NCT06381479 — Exploring the Effects of Probiotics on Workplace Related Stress Symptoms · NA · completed
NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn

Other recruiting trials for Cholestatic Liver Disease

Currently open trials in the same condition.

NCT07317193 — DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE · NA · recruiting
NCT06825559 — Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease · Phase 1 · recruiting
NCT05045482 — Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease · Phase 1 · recruiting

Other Indonesia University trials

Trials by the same sponsor.

NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04787419 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesia University
Last refreshed: 3 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04787419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing